ResearcherDalian Medical UniversityNo recent work listed
Zhongyu Wang
Matched on ORCID iD 0000-0002-2626-8430; OpenAlex author ID A5078610772. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 6
2012: 1 paper · 2013: none · 2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper
Papers 4
- [Corrigendum] USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β‑catenin nuclear localization and is associated with poor prognosi… Last author DOI 10.3892/ijo.2019.4871↗
- USP22 promotes epithelial-mesenchymal transition via the FAK pathway in pancreatic cancer cells. Last author DOI 10.3892/or.2014.3354↗
- Abnormal expression of Nek2 in pancreatic ductal adenocarcinoma: a novel marker for prognosis. Last author PMID 24966957↗
- Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells. Last author DOI 10.3892/ijmm.2012.884↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zhen Ning · 3 shared papers, 2014–2019 · strength 0.20
- Paper [Corrigendum] USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β‑catenin nuclear localizat… DOI 10.3892/ijo.2019.4871↗
- Paper USP22 promotes epithelial-mesenchymal transition via the FAK pathway in pancreatic cancer cells. DOI 10.3892/or.2014.3354↗
- Paper Abnormal expression of Nek2 in pancreatic ductal adenocarcinoma: a novel marker for prognosis. PMID 24966957↗
- Aman Wang · 3 shared papers, 2014–2019 · strength 0.20
- Paper [Corrigendum] USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β‑catenin nuclear localizat… DOI 10.3892/ijo.2019.4871↗
- Paper USP22 promotes epithelial-mesenchymal transition via the FAK pathway in pancreatic cancer cells. DOI 10.3892/or.2014.3354↗
- Paper Abnormal expression of Nek2 in pancreatic ductal adenocarcinoma: a novel marker for prognosis. PMID 24966957↗
- Jiwei Liu · 2 shared papers, 2014 · strength 0.09
- Bo Tang · 1 shared paper, 2012 · strength 0.03
- Liming Wang · 1 shared paper, 2012 · strength 0.03
- Jian Du · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.